Direct contact and droplets are the primary ways influenza spreads. Under certain conditions, however, aerosol transmission is possible. In a study published in the current issue of Clinical Infectious Diseases, available online, the authors examined such an outbreak in their own hospital in Hong Kong.
On April 4, 2008, seven inpatients in the hospitals general medical ward developed fever and respiratory symptoms. Ultimately, nine inpatients exhibited influenza-like symptoms and tested positive for influenza A. The cause of the outbreak was believed to be an influenza patient who was admitted on March 27. He received a form of non-invasive ventilation on March 31, and was then moved to the intensive care unit after 16 hours. During that time, he was located right beside the outflow jet of an air purifier, which created an unopposed air current across the ward.
"We showed that infectious aerosols generated by a respiratory device applied to an influenza patient might have been blown across the hospital ward by an imbalanced indoor airflow, causing a major nosocomial outbreak," says study author Nelson Lee, MD, of the Chinese University of Hong Kong. "The spatial distribution of affected patients was highly consistent with an aerosol mode of transmission, as opposed to that expected from droplet transmission.
"Suitable personal protective equipment, including the use of N95 respirators, will need to be considered when aerosol-generating procedures are performed on influenza patients," Lee adds. "Avoiding such procedures in open wards and improving ventilation design in healthcare facilities may also help to reduce the risk of nosocomial transmission of influenza."
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.